Key points are not available for this paper at this time.
No takes yet. Share an insight, caveat, or question.
Identifies CD47 as platelet activator; leaves open therapeutic targeting in thrombosis pending in vivo studies.
Chung et al. (1997) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: